We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

CEPHEID

Develops, manufactures, and markets molecular systems and tests for institutions to perform sophisticated genetic tes... read more Featured Products: More products

Download Mobile App




Molecular Stool Test Shows Potential for Diagnosing TB in Adults with HIV

By LabMedica International staff writers
Posted on 08 May 2025

Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis, led to 1. More...

25 million deaths in 2023, with 13% of those occurring in people living with HIV. The current primary diagnostic method for TB relies on sputum samples, which are collected by deep coughing and expectoration of lung secretions. The World Health Organization (WHO) recommends molecular sputum tests for individuals living with HIV, in addition to urine antigen detection (TB-LAM). However, access to these tests remains limited in many regions, and they are not suitable for all individuals with HIV. Specifically, people with HIV often have difficulty producing sputum; more than half of those in advanced stages of the disease are unable to do so. Moreover, the bacteria concentration in the sputum is frequently too low to detect. To overcome this challenge, researchers have proposed using a molecular test, which is currently employed on respiratory samples, for stool samples instead to test for TB.

Cepheid’s (Sunnyvale, CA, USA) Xpert MTB/Ultra molecular diagnostic test, which has thus far only been recommended for children, could also be used to diagnose tuberculosis in HIV-positive adults. This was the central conclusion of the Stool4TB Alliance study, led by the Barcelona Institute for Global Health (ISGlobal, Barcelona, Spain). Published in The Lancet Microbe, the results could potentially lead to a paradigm shift in diagnosing TB among this population. The test is currently recommended for children who have difficulty producing sputum. The study, conducted between December 2021 and August 2024 in medical centers across three African countries, included 677 HIV-positive patients aged 15 and older with suspected TB.

Participants provided sputum, urine, stool, and blood samples. The results revealed that the stool test had a sensitivity of 23.7% and a specificity of 94.0% when compared to the reference standard. For patients with CD4 counts below 200 cells/μl, sensitivity increased to 45.5%. CD4 lymphocytes are immune cells that are damaged by HIV infection, making individuals with CD4 counts below 200 more susceptible to serious opportunistic infections, including tuberculosis. Additionally, the Stool Ultra test identified cases of TB that were missed by other methods, such as TB-LAM, Ultra sputum tests, or bacterial cultures.

“People living with HIV are at higher risk of developing pulmonary tuberculosis, but diagnosis in these cases is particularly challenging due to the low sensitivity of conventional tests,” explains George William Kasule, a PhD student at ISGlobal and the University of Barcelona, and the first author of the study. “The variety of samples obtained in this study allowed us to compare the sensitivity and specificity of the Stool Ultra test with a microbiological reference standard consisting of three WHO-recommended tests: TB-LAM in urine, liquid culture, and Xpert Ultra from sputum.”

Related Links:
ISGlobal


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
New
Francisella Tularensis Test
TULAREMIA VIRCLIA IgG+IgM MONOTEST
New
Hepatitis A Rapid Test
Anti-HAV IgM Rapid Test Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The POC device rapidly predicts neonatal respiratory disease at birth in the NICU (Photo courtesy of SIME Diagnostics)

AI-Powered Lung Maturity Test Identifies Newborns at Higher Risk of Respiratory Distress

Each year, approximately 300,000 babies in the United States are born between 32 and 36 weeks' gestation, according to national health data. This group is at an elevated risk for respiratory distress,... Read more

Molecular Diagnostics

view channel
Image: The new study findings emphasize the need for incorporating disease heterogeneity into type 2 diabetes care strategies (Photo courtesy of Cell 2025; doi.org/10.1016/j.cell.2025.05.00)

Molecular Fingerprint for Insulin Sensitivity Could Diagnose Diabetes Before Disease Develops

Insulin is a hormone essential for regulating blood sugar levels, and its dysfunction is a key factor in the development of diabetes. Insulin resistance, a condition where the body's cells do not respond... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Custom hardware and software for the real-time detection of immune cell biophysical signatures in NICU (Photo courtesy of Pediatric Research, DOI:10.1038/s41390-025-03952-y)

First-Of-Its-Kind Device Profiles Newborns' Immune Function Using Single Blood Drop

Premature infants are highly susceptible to severe and life-threatening conditions, such as sepsis and necrotizing enterocolitis (NEC). Newborn sepsis, which is a bloodstream infection occurring in the... Read more

Pathology

view channel
Image: Results of AI-based 3D virtual H&E staining and quantitative analysis of pathological tissue (Photo courtesy of Nature Communications, DOI:10.1038/s41467-025-59820-0)

Virtual Staining Technology Paves Way for Non-Invasive Pathological Diagnosis

For more than 200 years, traditional pathology has depended on the technique of examining cancer tissues under a microscope, a method that provides only limited, specific cross-sections of the 3D structure... Read more

Technology

view channel
Image: Concept of biosensor integrated into hygiene pads enabling direct semi-quantitative analysis of biomarkers in unprocessed menstruation blood (Photo courtesy of Dosnon, L et al. DOI: 10.1002/advs.202505170)

First Ever Technology Recognizes Disease Biomarkers Directly in Menstrual Blood in Sanitary Towels

Over 1.8 billion people menstruate worldwide, yet menstrual blood has been largely overlooked in medical practice. This blood contains hundreds of proteins, many of which correlate with their concentration... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.